KHEPRI PHARMACEUTICALS

Khepri Pharmaceuticals is a biopharmaceutical company that develops proteases and their inhibitors as therapeutics. The company was founded in 1992 and is headquartered in South San Francisco, California.

#People #Financial #More

KHEPRI PHARMACEUTICALS

Industry:
Biopharma Biotechnology Life Science Pharmaceutical

Founded:
1992-09-01

Address:
South San Francisco, California, United States

Country:
United States

Total Employee:
1+

Status:
Active

Total Funding:
6.8 M USD


Current Employees Featured

not_available_image

Ronald Henriksen
Ronald Henriksen President & CEO @ Khepri Pharmaceuticals
President & CEO

Investors List

brentwood-associates_image

Brentwood Associates

Brentwood Associates investment in Venture Round - Khepri Pharmaceuticals

sequoia-capital_image

Sequoia Capital

Sequoia Capital investment in Venture Round - Khepri Pharmaceuticals

mayfield-fund_image

Mayfield Fund

Mayfield Fund investment in Venture Round - Khepri Pharmaceuticals

sierra-ventures_image

Sierra Ventures

Sierra Ventures investment in Venture Round - Khepri Pharmaceuticals

More informations about "Khepri Pharmaceuticals"

Khepri Pharmaceuticals, Inc. (Khepri Pharmaceuticals, Inc.) - ่ฏ็‰ฉ็ฎก โ€ฆ

100 ้กนไธŽ Khepri Pharmaceuticals, Inc. ็›ธๅ…ณ็š„ไธดๅบŠ็ป“ๆžœ ็™ปๅฝ•ๅŽๆŸฅ็œ‹ๆ›ดๅคšไฟกๆฏ 0 ้กนไธŽ Khepri Pharmaceuticals, Inc. ็›ธๅ…ณ็š„ไธ“ๅˆฉ๏ผˆๅŒป่ฏ๏ผ‰ ็™ปๅฝ•ๅŽๆŸฅ็œ‹ๆ›ดๅคšไฟกๆฏ 10 ้กนไธŽ Khepri โ€ฆSee details»

Khepri | Khepri Fund Management

Khepri provides expert regulatory and compliance solutions for financial firms, offering tailored fund management and corporate services to streamline operations and ensure industry compliance.See details»

Khepri Pharmaceuticals | www.inknowvation.com

With strong ties to Genentech (an inital investor), Khepri Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of novel drugs based on proteases and โ€ฆSee details»

Khepri Pharmaceuticals - Crunchbase Company Profile & Funding

Khepri Pharmaceuticals is a biopharmaceutical company that develops proteases and their inhibitors as therapeutics.See details»

Our People | Portfolio And Risk Management โ€” Khepri

Our expert team at Khepri brings together diverse backgrounds and deep industry knowledge to support your business with top-notch fund management and compliance services.See details»

Produits Pharmaceutiques Khepri Canada, Inc. · Khepri โ€ฆ

PRODUITS PHARMACEUTIQUES KHEPRI CANADA, INC. (also known as KHEPRI PHARMACEUTICALS CANADA, INC.) is a business entity in registered with the Business โ€ฆSee details»

KHEPRI PHARMACEUTICALS, INC. :: Delaware (US) :: OpenCorporates

Free and open company data on Delaware (US) company KHEPRI PHARMACEUTICALS, INC. (company number 2295572)See details»

KHEPRI PHARMACEUTICALS Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for KHEPRI PHARMACEUTICALS of Hyderabad, Telangana. Get the latest business insights from Dun & โ€ฆSee details»

Khepri Pharmaceuticals Canada, Inc./Produits Pharmaceutiques โ€ฆ

Khepri Pharmaceuticals Canada, Inc./Produits Pharmaceutiques Khepri Canada Inc.Montréal,QCSee details»

Axys Pharmaceuticals acquires Khepri Pharmaceuticals - 1995-11 โ€ฆ

Nov 20, 1995 Overview Acquired Organization: Khepri Pharmaceuticals Khepri Pharmaceuticals is a biopharmaceutical company that develops proteases and their inhibitors as therapeutics.See details»

Khepri Pharmaceuticals Canada, Inc./Produits Pharmaceutiques โ€ฆ

Loi sur Investissement Canada Khepri Pharmaceuticals Canada, Inc./Produits Pharmaceutiques Khepri Canada Inc.See details»

Khepri Pharmaceuticals - Products, Competitors, Financials, โ€ฆ

About Khepri Pharmaceuticals Producer of novel therapeutics based on proteases and protease inhibitors. Initial clinical targets are inflammation, cancer, and infectious disease. The company โ€ฆSee details»

Khepri Pharmaceuticals - Funding, Financials, Valuation & Investors

Khepri Pharmaceuticals is a biopharmaceutical company that develops proteases and their inhibitors as therapeutics.See details»

Khepri Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical trials ...

May 8, 2025 Explore Khepri Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 10 literature, Drug:ICI-1.See details»

Khepri Pharmaceuticals - Crunchbase

Khepri Pharmaceuticals, Quadriga BioSciences, ProFound Pharma, Ichorion Therapeutics, Alitair Pharmaceuticals, and Comanche Biopharma operate in the biopharmaceutical industry. โ€ฆSee details»

ICI-1 - Drug Targets, Indications, Patents - Synapse

3 days ago ICI-1: a cysteine protease inhibitors Drug, Initially developed by Khepri Pharmaceuticals, Inc., Now, its global highest R&D status is Pending, Mechanism: cysteine โ€ฆSee details»

Khepri Pharmaceuticals Stock Price, Funding, Valuation, Revenue ...

See Khepri Pharmaceuticals funding rounds, investors, investments, exits and more. Evaluate their financials based on Khepri Pharmaceuticals's post-money valuation and revenue.See details»

Khepri Pharmaceuticals CEO, Founder, Key Executive Team, Board โ€ฆ

Explore {Khepri Pharmaceuticals's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»

Khepri Pharmaceuticals Company Profile 2024: Valuation, Investors ...

Information on acquisition, funding, cap tables, investors, and executives for Khepri Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»

K-11002 - Drug Targets, Indications, Patents - Synapse

K-11002: a CTSA inhibitors, cysteine protease inhibitors Drug, Initially developed by Khepri Pharmaceuticals, Inc., Now, its global highest R&D status is Pending, Mechanism: CTSA โ€ฆSee details»

linkstock.net © 2022. All rights reserved